303 related articles for article (PubMed ID: 28403782)
1. Synthesis, Cytotoxicity and Antimicrobial Activity of New Enmein-type Kauranoid Diterpenoid Derivatives.
Li D; Han T; Hu X; Tian K; Xu S; Zhou T; Cheng K; Li Z; Hua H; Xu J
Anticancer Agents Med Chem; 2017; 17(12):1679-1688. PubMed ID: 28403782
[TBL] [Abstract][Full Text] [Related]
2. Lasiokaurin derivatives: synthesis, antimicrobial and antitumor biological evaluation, and apoptosis-inducing effects.
Li DH; Hu P; Xu ST; Fang CY; Tang S; Wang XY; Sun XY; Li H; Xu Y; Gu XK; Xu JY
Arch Pharm Res; 2017 Jul; 40(7):796-806. PubMed ID: 28110416
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Biological Activity, and Apoptotic Properties of NO-Donor/Enmein-Type ent-Kauranoid Hybrids.
Li D; Hu X; Han T; Xu S; Zhou T; Wang Z; Cheng K; Li Z; Hua H; Xiao W; Xu J
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231893
[TBL] [Abstract][Full Text] [Related]
4. Bioactive enmein-type 6,7-seco-ent-kaurane diterpenoids: natural products, synthetic derivatives and apoptosis related mechanism.
Li H; Sun B; Wang M; Hu X; Gao X; Xu S; Xu Y; Xu J; Hua H; Li D
Arch Pharm Res; 2018 Nov; 41(11):1051-1061. PubMed ID: 30242610
[TBL] [Abstract][Full Text] [Related]
5. Effective enmein-type mimics of clinical candidate HAO472: Design, synthesis and biological evaluation.
Hu X; Bai Z; Qiao J; Li H; Xu S; Wang X; Xu Y; Xu J; Hua H; Li D
Eur J Med Chem; 2019 Jun; 171():169-179. PubMed ID: 30921757
[TBL] [Abstract][Full Text] [Related]
6. Novel enmein-type diterpenoid hybrids coupled with nitrogen mustards: Synthesis of promising candidates for anticancer therapeutics.
Gao X; Li J; Wang M; Xu S; Liu W; Zang L; Li Z; Hua H; Xu J; Li D
Eur J Med Chem; 2018 Feb; 146():588-598. PubMed ID: 29407983
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen sulfide releasing enmein-type diterpenoid derivatives as apoptosis inducers through mitochondria-related pathways.
Xu F; Gao X; Li H; Xu S; Li X; Hu X; Li Z; Xu J; Hua H; Li D
Bioorg Chem; 2019 Feb; 82():192-203. PubMed ID: 30326401
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen sulfide donating ent-kaurane and spirolactone-type 6,7-seco-ent-kaurane derivatives: Design, synthesis and antiproliferative properties.
Li H; Gao X; Huang X; Wang X; Xu S; Uchita T; Gao M; Xu J; Hua H; Li D
Eur J Med Chem; 2019 Sep; 178():446-457. PubMed ID: 31202992
[TBL] [Abstract][Full Text] [Related]
9. Enmein-type diterpenoid analogs from natural kaurene-type oridonin: Synthesis and their antitumor biological evaluation.
Li D; Xu S; Cai H; Pei L; Zhang H; Wang L; Yao H; Wu X; Jiang J; Sun Y; Xu J
Eur J Med Chem; 2013 Jun; 64():215-21. PubMed ID: 23644204
[TBL] [Abstract][Full Text] [Related]
10. NO-Releasing Enmein-Type Diterpenoid Derivatives with Selective Antiproliferative Activity and Effects on Apoptosis-Related Proteins.
Li D; Hu X; Han T; Liao J; Xiao W; Xu S; Li Z; Wang Z; Hua H; Xu J
Molecules; 2016 Sep; 21(9):. PubMed ID: 27617998
[TBL] [Abstract][Full Text] [Related]
11. The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents.
Wang L; Li D; Xu S; Cai H; Yao H; Zhang Y; Jiang J; Xu J
Eur J Med Chem; 2012 Jun; 52():242-50. PubMed ID: 22483090
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of spirolactone-type diterpenoid derivatives from kaurene-type oridonin with improved antiproliferative effects and their apoptosis-inducing activity in human hepatoma Bel-7402 cells.
Li D; Cai H; Jiang B; Liu G; Wang Y; Wang L; Yao H; Wu X; Sun Y; Xu J
Eur J Med Chem; 2013 Jan; 59():322-8. PubMed ID: 23274570
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and cytotoxicity of the conjugates of diterpenoid isosteviol and
Garifullin BF; Strobykina IY; Khabibulina LR; Sapunova AS; Voloshina AD; Sharipova RR; Khairutdinov BI; Zuev YF; Kataev VE
Nat Prod Res; 2021 Apr; 35(8):1372-1378. PubMed ID: 31402704
[TBL] [Abstract][Full Text] [Related]
14. Library construction and biological evaluation of enmein-type diterpenoid analogues as potential anticancer agents.
Li D; Xu S; Cai H; Pei L; Wang L; Wu X; Yao H; Jiang J; Sun Y; Xu J
ChemMedChem; 2013 May; 8(5):812-8. PubMed ID: 23520191
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of Oridonin Derivatives via Mizoroki-Heck Reaction and Click Chemistry for Cytotoxic Activity.
Hou W; Fan Q; Su L; Xu H
Anticancer Agents Med Chem; 2019; 19(7):935-947. PubMed ID: 30657049
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Cytotoxicity Assessment of Novel 7-O- and 14-O-Derivatives of Glaucocalyxin A.
Liu HC; Qiao LM; Zheng W; Xiang ZB; Chen HS; Yu SC; Zhang DZ; Wang T; Zhang YF; Jin YS
Anticancer Agents Med Chem; 2020; 20(10):1241-1249. PubMed ID: 32116205
[TBL] [Abstract][Full Text] [Related]
17. Novel nitric oxide-releasing spirolactone-type diterpenoid derivatives with in vitro synergistic anticancer activity as apoptosis inducer.
Li D; Han T; Tian K; Tang S; Xu S; Hu X; Wang L; Li Z; Hua H; Xu J
Bioorg Med Chem Lett; 2016 Sep; 26(17):4191-6. PubMed ID: 27491707
[TBL] [Abstract][Full Text] [Related]
18. Antitumor and Antibacterial Derivatives of Oridonin: A Main Composition of Dong-Ling-Cao.
Li D; Han T; Xu S; Zhou T; Tian K; Hu X; Cheng K; Li Z; Hua H; Xu J
Molecules; 2016 Apr; 21(5):. PubMed ID: 27144553
[TBL] [Abstract][Full Text] [Related]
19. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antimycobacterial evaluation of natural oridonin and its enmein-type derivatives.
Xu S; Pei L; Li D; Yao H; Cai H; Yao H; Wu X; Xu J
Fitoterapia; 2014 Dec; 99():300-6. PubMed ID: 25316557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
